Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Nov-16 9:45 PM View:  | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 47,613 | $28.35 | $1,349,830.00 | (100%) 47.61K to 0 | |
| 14-Oct-16 12:04 PM View: | Reshape Lifesciences Inc. (OBLN) | 12-Oct-16 | Conversion | 49,570 | -- | -- | 100% 0 to 49.57K | |
| 27-May-16 5:26 PM View: | Evoke Pharma Inc (EVOK) | 26-May-16 | Sale | 5,880 | $4.70 | $27,636.00 | (36%) 16.21K to 10.33K | |
| 27-Apr-16 8:37 PM View: | Evoke Pharma Inc (EVOK) | 27-Apr-16 | Market Sale | 61 | $5.02 | $306.22 | (< 1%) 16.27K to 16.21K | 47% |
| 27-Apr-16 8:37 PM View: | Evoke Pharma Inc (EVOK) | 25-Apr-16 | Market Sale | 21 | $5.20 | $109.20 | (< 1%) 16.29K to 16.27K | 49% |
| 21-Apr-16 5:12 PM View: | Evoke Pharma Inc (EVOK) | 20-Apr-16 | Market Sale | 76 | $5.29 | $402.04 | (< 1%) 16.37K to 16.29K | 50% |
| 21-Apr-16 5:12 PM View: | Evoke Pharma Inc (EVOK) | 19-Apr-16 | Market Sale | 632 | $5.36 | $3,387.52 | (4%) 17.0K to 16.37K | 51% |
| 13-Apr-16 7:31 PM View: | Evoke Pharma Inc (EVOK) | 11-Apr-16 | Market Sale | 75 | $5.22 | $391.50 | (< 1%) 17.07K to 17.0K | 49% |
| 08-Apr-16 8:51 PM View: | Evoke Pharma Inc (EVOK) | 08-Apr-16 | Market Sale | 251 | $5.35 | $1,342.85 | (1%) 17.32K to 17.07K | 51% |
| 08-Apr-16 8:51 PM View: | Evoke Pharma Inc (EVOK) | 07-Apr-16 | Market Sale | 475 | $5.26 | $2,498.50 | (3%) 17.8K to 17.32K | 50% |
| 08-Apr-16 8:51 PM View: | Evoke Pharma Inc (EVOK) | 06-Apr-16 | Market Sale | 148 | $5.22 | $772.56 | (< 1%) 17.95K to 17.8K | 49% |
| 20-Aug-15 5:01 PM View: | Evoke Pharma Inc (EVOK) | 18-Aug-15 | Market Sale | 202 | $7.02 | $1,418.04 | (1%) 18.15K to 17.95K | 62% |
| 16-Apr-15 7:44 PM View: | Evoke Pharma Inc (EVOK) | 16-Apr-15 | Market Sale | 554 | $7.07 | $3,916.78 | (3%) 18.7K to 18.15K | 63% |
| 16-Apr-15 7:44 PM View: | Evoke Pharma Inc (EVOK) | 15-Apr-15 | Market Sale | 135 | $7.58 | $1,023.30 | (< 1%) 18.84K to 18.7K | 65% |
| 16-Apr-15 7:44 PM View: | Evoke Pharma Inc (EVOK) | 14-Apr-15 | Market Sale | 168 | $7.78 | $1,307.04 | (< 1%) 19.01K to 18.84K | 66% |
| 26-Nov-14 11:10 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Conversion | 46,309 | -- | -- | 100% 0 to 46.31K | |
| 26-Nov-14 11:10 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Payment of Exercise | 2,683 | $14.00 | $37,562.00 | (5%) 50.71K to 48.02K | |
| 26-Nov-14 11:10 AM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Option Exercise | 4,397 | $8.54 | $37,550.40 | 9% 46.31K to 50.71K | |
| 21-Mar-14 6:27 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition | 50,743 | $14.00 | $710,402.00 | (100%) 50.74K to 0 | < 1% |
| 17-Mar-14 3:14 PM View: | Achaogen, Inc. (AKAO) | 17-Mar-14 | Conversion | 33,890 | -- | -- | 100% 0 to 33.89K | |
| 14-Feb-14 5:03 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 13,058 | $14.00 | $182,812.00 | (20%) 63.8K to 50.74K | |
| 14-Feb-14 5:03 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 23,317 | $7.84 | $182,805.00 | 58% 40.48K to 63.8K | |
| 19-Nov-13 6:26 PM View: | Tandem Diabetes Care Inc (TNDM) | 19-Nov-13 | Conversion | 54,390 | -- | -- | 100% 0 to 54.39K | |
| 30-Sep-13 5:15 PM View: | Evoke Pharma Inc (EVOK) | 30-Sep-13 | Conversion | 19,006 | -- | -- | 100% 0 to 19.01K | |
| 02-Jul-13 5:00 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion | 30,462 | -- | -- | 100% 0 to 30.46K | |
| 02-Jul-13 5:00 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase | 4,791 | $14.00 | $67,074.00 | 16% 30.46K to 35.25K | |
| 05-Jun-13 5:52 PM View: | Clovis Oncology, Inc. (CLVS) | 04-Jun-13 | Market Sale | 2,779 | $64.58 | $179,468.00 | (6%) 46.81K to 44.03K | 92% |
| 22-Mar-13 6:16 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 21-Mar-13 | Market Sale (Planned) | 893 | $5.49 | $4,902.57 | (2%) 41.38K to 40.48K | (44%) |
| 21-Mar-13 5:10 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Mar-13 | Market Sale (Planned) | 92 | $5.22 | $480.24 | (< 1%) 41.47K to 41.38K | (51%) |
| 21-Mar-13 5:10 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-13 | Market Sale (Planned) | 134 | $5.19 | $695.46 | (< 1%) 41.6K to 41.47K | (52%) |
| 19-Mar-13 4:43 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Mar-13 | Market Sale (Planned) | 135 | $5.16 | $696.60 | (< 1%) 41.74K to 41.6K | (53%) |
| 19-Mar-13 4:43 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Mar-13 | Market Sale (Planned) | 163 | $5.28 | $860.64 | (< 1%) 41.9K to 41.74K | (49%) |
| 15-Mar-13 4:59 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Mar-13 | Market Sale (Planned) | 85 | $5.36 | $455.60 | (< 1%) 41.99K to 41.9K | (47%) |
| 15-Mar-13 4:59 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Mar-13 | Market Sale (Planned) | 131 | $5.40 | $707.40 | (< 1%) 42.12K to 41.99K | (46%) |
| 13-Mar-13 8:38 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Mar-13 | Market Sale (Planned) | 107 | $5.38 | $575.66 | (< 1%) 42.22K to 42.12K | (46%) |
| 13-Mar-13 8:38 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 11-Mar-13 | Market Sale (Planned) | 70 | $5.34 | $373.80 | (< 1%) 42.29K to 42.22K | (48%) |
| 11-Mar-13 6:35 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 08-Mar-13 | Market Sale (Planned) | 88 | $5.32 | $468.16 | (< 1%) 42.38K to 42.29K | (48%) |
| 11-Mar-13 6:35 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 07-Mar-13 | Market Sale (Planned) | 215 | $5.22 | $1,122.30 | (< 1%) 42.6K to 42.38K | (51%) |
| 07-Mar-13 6:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 06-Mar-13 | Market Sale (Planned) | 65 | $5.06 | $328.90 | (< 1%) 42.66K to 42.6K | (56%) |
| 06-Mar-13 6:25 PM View: | Clovis Oncology, Inc. (CLVS) | 06-Mar-13 | Market Sale | 1,651 | $24.51 | $40,466.00 | (3%) 48.46K to 46.81K | 80% |
| 07-Mar-13 6:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 05-Mar-13 | Market Sale (Planned) | 69 | $5.01 | $345.69 | (< 1%) 42.73K to 42.66K | (57%) |
| 06-Mar-13 6:25 PM View: | Clovis Oncology, Inc. (CLVS) | 05-Mar-13 | Market Sale | 2,132 | $24.69 | $52,639.10 | (4%) 50.6K to 48.46K | 80% |
| 05-Mar-13 5:18 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 04-Mar-13 | Market Sale (Planned) | 88 | $5.01 | $440.88 | (< 1%) 42.82K to 42.73K | (57%) |
| 06-Mar-13 6:25 PM View: | Clovis Oncology, Inc. (CLVS) | 04-Mar-13 | Market Sale | 417 | $24.44 | $10,191.50 | (< 1%) 51.01K to 50.6K | 80% |
| 05-Mar-13 5:18 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 01-Mar-13 | Market Sale (Planned) | 130 | $5.01 | $651.30 | (< 1%) 42.95K to 42.82K | (57%) |
| 22-Feb-13 4:53 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Feb-13 | Market Sale (Planned) | 34 | $5.01 | $170.34 | (< 1%) 42.98K to 42.95K | (57%) |
| 20-Feb-13 4:55 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Feb-13 | Market Sale (Planned) | 171 | $5.02 | $858.42 | (< 1%) 43.15K to 42.98K | (57%) |
| 20-Feb-13 4:55 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 15-Feb-13 | Market Sale (Planned) | 51 | $5.00 | $255.00 | (< 1%) 43.2K to 43.15K | (58%) |
| 15-Feb-13 5:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 14-Feb-13 | Market Sale (Planned) | 51 | $5.01 | $255.51 | (< 1%) 43.26K to 43.2K | (57%) |
| 15-Feb-13 5:12 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 13-Feb-13 | Market Sale (Planned) | 98 | $5.00 | $490.00 | (< 1%) 43.35K to 43.26K | (58%) |